Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Failure, Chronic | 8 | 2021 | 930 | 1.280 |
Why?
|
| Renal Dialysis | 7 | 2021 | 947 | 0.950 |
Why?
|
| Atrial Fibrillation | 4 | 2019 | 736 | 0.830 |
Why?
|
| Kidney Glomerulus | 2 | 2019 | 80 | 0.700 |
Why?
|
| Hepatitis B | 1 | 2022 | 170 | 0.650 |
Why?
|
| Vascular Diseases | 1 | 2022 | 147 | 0.640 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2018 | 848 | 0.610 |
Why?
|
| Glucaric Acid | 2 | 2017 | 8 | 0.590 |
Why?
|
| Lupus Nephritis | 1 | 2019 | 42 | 0.580 |
Why?
|
| Ferric Compounds | 2 | 2017 | 39 | 0.570 |
Why?
|
| Liver Diseases | 1 | 2022 | 378 | 0.540 |
Why?
|
| Kidney Diseases | 1 | 2022 | 472 | 0.530 |
Why?
|
| Terminology as Topic | 1 | 2019 | 226 | 0.520 |
Why?
|
| Sevelamer | 1 | 2016 | 11 | 0.500 |
Why?
|
| Cause of Death | 2 | 2018 | 502 | 0.500 |
Why?
|
| Hyperphosphatemia | 1 | 2016 | 19 | 0.500 |
Why?
|
| Albuminuria | 1 | 2017 | 106 | 0.480 |
Why?
|
| Ferrosoferric Oxide | 1 | 2015 | 25 | 0.450 |
Why?
|
| Anemia | 2 | 2017 | 352 | 0.440 |
Why?
|
| Myocardial Infarction | 2 | 2018 | 997 | 0.400 |
Why?
|
| Nephritis, Interstitial | 1 | 2013 | 41 | 0.380 |
Why?
|
| Anemia, Sickle Cell | 1 | 2017 | 332 | 0.380 |
Why?
|
| Stroke | 2 | 2018 | 1059 | 0.380 |
Why?
|
| Kidney | 1 | 2017 | 1279 | 0.320 |
Why?
|
| Kidney Transplantation | 3 | 2021 | 552 | 0.290 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 1325 | 0.240 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 700 | 0.230 |
Why?
|
| Hematinics | 2 | 2017 | 60 | 0.230 |
Why?
|
| Prognosis | 4 | 2018 | 4848 | 0.200 |
Why?
|
| Aged | 9 | 2021 | 20821 | 0.190 |
Why?
|
| Glomerular Filtration Rate | 2 | 2018 | 566 | 0.170 |
Why?
|
| Male | 12 | 2022 | 64386 | 0.160 |
Why?
|
| United States | 5 | 2021 | 11896 | 0.160 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 5167 | 0.160 |
Why?
|
| Female | 12 | 2022 | 70246 | 0.150 |
Why?
|
| History, 16th Century | 1 | 2019 | 26 | 0.150 |
Why?
|
| Nephrology | 1 | 2021 | 159 | 0.150 |
Why?
|
| History, Ancient | 1 | 2019 | 52 | 0.150 |
Why?
|
| Humans | 16 | 2022 | 130085 | 0.150 |
Why?
|
| History, 18th Century | 1 | 2019 | 68 | 0.150 |
Why?
|
| History, 19th Century | 1 | 2019 | 110 | 0.140 |
Why?
|
| Waiting Lists | 1 | 2021 | 251 | 0.140 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 6765 | 0.140 |
Why?
|
| Perioperative Care | 1 | 2021 | 217 | 0.140 |
Why?
|
| Health Policy | 1 | 2021 | 225 | 0.140 |
Why?
|
| Neoplasms | 1 | 2013 | 2975 | 0.140 |
Why?
|
| Administration, Intravenous | 2 | 2017 | 172 | 0.140 |
Why?
|
| History, 21st Century | 1 | 2019 | 259 | 0.140 |
Why?
|
| History, 20th Century | 1 | 2019 | 361 | 0.130 |
Why?
|
| Tissue and Organ Procurement | 1 | 2021 | 253 | 0.130 |
Why?
|
| Hypernatremia | 1 | 2017 | 32 | 0.120 |
Why?
|
| Chelating Agents | 1 | 2016 | 52 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2022 | 802 | 0.120 |
Why?
|
| Hyponatremia | 1 | 2017 | 73 | 0.120 |
Why?
|
| Phosphates | 1 | 2016 | 112 | 0.120 |
Why?
|
| Biopsy | 1 | 2019 | 1240 | 0.110 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 1393 | 0.110 |
Why?
|
| Incidence | 2 | 2018 | 3321 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2019 | 1344 | 0.100 |
Why?
|
| Middle Aged | 5 | 2018 | 28314 | 0.100 |
Why?
|
| Comorbidity | 1 | 2018 | 1584 | 0.100 |
Why?
|
| Registries | 1 | 2018 | 1607 | 0.080 |
Why?
|
| Living Donors | 1 | 2010 | 110 | 0.080 |
Why?
|
| Heart Failure | 1 | 2021 | 2325 | 0.070 |
Why?
|
| Risk Factors | 1 | 2018 | 10960 | 0.050 |
Why?
|
| Health Care Rationing | 1 | 2021 | 58 | 0.040 |
Why?
|
| Europe | 1 | 2021 | 363 | 0.040 |
Why?
|
| Language | 1 | 2021 | 217 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2018 | 5034 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 442 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2010 | 3114 | 0.030 |
Why?
|
| Hypotension | 1 | 2019 | 186 | 0.030 |
Why?
|
| Adult | 2 | 2013 | 31011 | 0.030 |
Why?
|
| Mortality | 1 | 2017 | 263 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 698 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1112 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2018 | 17541 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 2107 | 0.020 |
Why?
|
| Age Factors | 1 | 2018 | 2822 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 257 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 1165 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2010 | 556 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 656 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 12821 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 2107 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 6165 | 0.010 |
Why?
|